Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
11.62
-0.15 (-1.27%)
Mar 31, 2025, 9:39 AM EDT - Market open

Company Description

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets.

The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer.

It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.

Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Sotera Health Company
Sotera Health Company logo
Country United States
Founded 2015
IPO Date Nov 20, 2020
Industry Diagnostics & Research
Sector Healthcare
Employees 3,000
CEO Michael Petras

Contact Details

Address:
9100 South Hills Blvd, Suite 300
Broadview Heights, Ohio 44147
United States
Phone 440 262 1410
Website soterahealth.com

Stock Details

Ticker Symbol SHC
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $23.00
CIK Code 0001822479
CUSIP Number 83601L102
ISIN Number US83601L1026
Employer ID 47-3531161
SIC Code 8090

Key Executives

Name Position
Michael B. Petras Jr. Chairman and Chief Executive Officer
Jonathan M. Lyons Senior Vice President and Chief Financial Officer
Alexander Dimitrief J.D. Senior Vice President, General Counsel and Secretary
Michael P. Rutz President of Sterigenics
Robert G. Hauzie Chief Information Officer
Kristin A. Gibbs Chief Marketing Officer
William O. Lehmann Jr., J.D., M.B.A. Senior Vice President of Strategy and Corporate Development
Sally R. Turner Chief Human Resources Officer
Danielle J. Menture Senior Vice President of Global Environmental, Health and Safety and Sustainability
Joseph A. Shrawder President of Nelson Labs

Latest SEC Filings

Date Type Title
Feb 27, 2025 10-K Annual Report
Feb 27, 2025 8-K Current Report
Jan 14, 2025 8-K Current Report
Jan 6, 2025 8-K Current Report
Nov 20, 2024 8-K Current Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 5, 2024 10-Q Quarterly Report
Nov 5, 2024 8-K Current Report